BioLineRx Ltd.'s chief scientific officer, Merril Gersten, will step down March 31.
The company is yet to announce a replacement for Gersten.
BioLineRx chief scientific officer to step down
Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022